RONALD G GELBMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RONALD G GELBMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RONALD G GELBMAN. RONALD G GELBMAN is Director in HAEMONETICS CORP ($HAE).
Latest Insider Trading Transactions of RONALD G GELBMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 35.50 | 10,353 | 367,552 | 0 | |
Nov 13 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 45.45 | 6,573 | 298,743 | 0 | |
Nov 13 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 118.26 | 16,926 | 2,001,669 | 48,384 | 65.3 K to 48.4 K (-25.92 %) |
Nov 13 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 35.50 | 10,353 | 367,552 | 65,310 | 55 K to 65.3 K (+18.84 %) |
Nov 13 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 45.45 | 6,573 | 298,743 | 54,957 | 48.4 K to 55 K (+13.59 %) |
Aug 12 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 134.15 | 1,696 | 227,518 | 48,384 | 50.1 K to 48.4 K (-3.39 %) |
Jul 26 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 1,460 | 0 | 50,080 | 48.6 K to 50.1 K (+3.00 %) |
Feb 19 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
Feb 19 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 86.52 | 8,196 | 709,118 | 53,062 | 61.3 K to 53.1 K (-13.38 %) |
Feb 19 2019 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 36.37 | 8,196 | 298,089 | 61,258 | 53.1 K to 61.3 K (+15.45 %) |
Dec 18 2018 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 103.02 | 4,329 | 445,974 | 53,062 | 57.4 K to 53.1 K (-7.54 %) |
Jul 30 2018 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 1,696 | 0 | 57,391 | 55.7 K to 57.4 K (+3.05 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 34.41 | 1,678 | 57,732 | 0 | |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 34.41 | 5,440 | 187,163 | 1,678 | |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 34.41 | 1,678 | 57,732 | 55,695 | 54 K to 55.7 K (+3.11 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.80 | 300 | 17,040 | 54,017 | 54.3 K to 54 K (-0.55 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.78 | 200 | 11,356 | 54,317 | 54.5 K to 54.3 K (-0.37 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.77 | 300 | 17,031 | 54,517 | 54.8 K to 54.5 K (-0.55 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.74 | 300 | 17,021 | 54,817 | 55.1 K to 54.8 K (-0.54 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.73 | 400 | 22,692 | 55,117 | 55.5 K to 55.1 K (-0.72 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.72 | 100 | 5,672 | 55,517 | 55.6 K to 55.5 K (-0.18 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.71 | 100 | 5,671 | 55,617 | 55.7 K to 55.6 K (-0.18 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.70 | 1,200 | 68,040 | 55,717 | 56.9 K to 55.7 K (-2.11 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.69 | 400 | 22,676 | 56,917 | 57.3 K to 56.9 K (-0.70 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.68 | 300 | 17,004 | 57,317 | 57.6 K to 57.3 K (-0.52 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.67 | 300 | 17,001 | 57,617 | 57.9 K to 57.6 K (-0.52 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.67 | 100 | 5,667 | 57,917 | 58 K to 57.9 K (-0.17 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.66 | 100 | 5,666 | 58,017 | 58.1 K to 58 K (-0.17 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.65 | 400 | 22,660 | 58,117 | 58.5 K to 58.1 K (-0.68 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.63 | 200 | 11,326 | 58,517 | 58.7 K to 58.5 K (-0.34 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.62 | 240 | 13,589 | 58,717 | 59 K to 58.7 K (-0.41 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.60 | 200 | 11,320 | 58,957 | 59.2 K to 59 K (-0.34 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.58 | 235 | 13,296 | 59,157 | 59.4 K to 59.2 K (-0.40 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 56.57 | 65 | 3,677 | 59,392 | 59.5 K to 59.4 K (-0.11 %) |
Nov 17 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 34.41 | 5,440 | 187,163 | 59,457 | 54 K to 59.5 K (+10.07 %) |
Jul 31 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 39.27 | 4,329 | 170,000 | 54,017 | 49.7 K to 54 K (+8.71 %) |
Apr 27 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 27.24 | 8,580 | 233,719 | 0 | |
Apr 27 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 40.00 | 8,580 | 343,200 | 49,688 | 58.3 K to 49.7 K (-14.73 %) |
Apr 27 2017 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 27.24 | 8,580 | 233,719 | 58,268 | 49.7 K to 58.3 K (+17.27 %) |
Dec 14 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 40.30 | 5,683 | 229,025 | 49,688 | 55.4 K to 49.7 K (-10.26 %) |
Aug 25 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 29.72 | 11,758 | 349,448 | 0 | |
Aug 25 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 29.72 | 11,758 | 349,448 | 66,985 | 55.2 K to 67 K (+21.29 %) |
Aug 25 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Payment of Exercise | F | 30.09 | 11,614 | 349,465 | 55,371 | 67 K to 55.4 K (-17.34 %) |
Jul 25 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 29.59 | 5,746 | 169,995 | 55,271 | 49.5 K to 55.3 K (+11.60 %) |
Jul 23 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 4,337 | 0 | 49,525 | 45.2 K to 49.5 K (+9.60 %) |
Mar 06 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 29.23 | 11,328 | 331,117 | 0 | |
Mar 06 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 44.76 | 7,707 | 344,936 | 45,188 | 52.9 K to 45.2 K (-14.57 %) |
Mar 06 2015 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 29.23 | 11,328 | 331,117 | 52,895 | 41.6 K to 52.9 K (+27.25 %) |
Jul 25 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 35.50 | 10,353 | 367,557 | 10,353 | |
Jul 25 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 2,394 | 0 | 41,567 | 39.2 K to 41.6 K (+6.11 %) |
Jun 13 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 24.96 | 9,184 | 229,233 | 0 | |
Jun 13 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 34.00 | 9,184 | 312,282 | 39,173 | 48.4 K to 39.2 K (-18.99 %) |
Jun 13 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 24.96 | 9,184 | 229,233 | 48,357 | 39.2 K to 48.4 K (+23.44 %) |
Mar 07 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 13.05 | 12,000 | 156,630 | 0 | |
Mar 07 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 36.17 | 12,000 | 434,015 | 39,173 | 51.2 K to 39.2 K (-23.45 %) |
Mar 07 2014 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 13.05 | 12,000 | 156,630 | 51,173 | 39.2 K to 51.2 K (+30.63 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.00 | 1,649 | 0 | 39,173 | 37.5 K to 39.2 K (+4.39 %) |
Dec 17 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 26.38 | 12,000 | 316,560 | 0 | |
Dec 17 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 11.28 | 12,000 | 135,330 | 0 | |
Dec 17 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 40.07 | 3,390 | 135,840 | 37,524 | 40.9 K to 37.5 K (-8.29 %) |
Dec 17 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 11.28 | 12,000 | 135,330 | 40,914 | 28.9 K to 40.9 K (+41.50 %) |
Dec 17 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 40.07 | 7,920 | 317,362 | 28,914 | 36.8 K to 28.9 K (-21.50 %) |
Dec 17 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 26.38 | 12,000 | 316,560 | 36,834 | 24.8 K to 36.8 K (+48.32 %) |
Aug 27 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 44.74 | 6,000 | 268,440 | 0 | |
Aug 27 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 71.90 | 6,000 | 431,400 | 12,417 | 18.4 K to 12.4 K (-32.58 %) |
Aug 27 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 44.74 | 6,000 | 268,440 | 18,417 | 12.4 K to 18.4 K (+48.32 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 1,031 | 10 | 12,417 | 11.4 K to 12.4 K (+9.05 %) |
May 21 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 71.49 | 2,473 | 176,795 | 11,386 | 13.9 K to 11.4 K (-17.84 %) |
Apr 25 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 31.66 | 6,000 | 189,960 | 0 | |
Apr 25 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 31.66 | 6,000 | 189,960 | 13,859 | 7.9 K to 13.9 K (+76.35 %) |
Jul 22 2011 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 68.81 | 3,559 | 244,895 | 3,559 | |
Jul 22 2011 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 944 | 9 | 7,859 | 6.9 K to 7.9 K (+13.65 %) |
Dec 28 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 32.01 | 6,000 | 192,060 | 0 | |
Dec 28 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 64.22 | 6,000 | 385,347 | 6,915 | 12.9 K to 6.9 K (-46.46 %) |
Dec 28 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 32.01 | 6,000 | 192,060 | 12,915 | 6.9 K to 12.9 K (+86.77 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 1,193 | 12 | 6,915 | 5.7 K to 6.9 K (+20.85 %) |
May 13 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 57.02 | 9,000 | 513,171 | 5,722 | 14.7 K to 5.7 K (-61.13 %) |
Apr 29 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 22.91 | 9,000 | 206,157 | 0 | |
Apr 29 2010 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 22.91 | 9,000 | 206,157 | 14,722 | 5.7 K to 14.7 K (+157.29 %) |
Sep 21 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 27.34 | 6,000 | 164,063 | 0 | |
Sep 21 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 55.78 | 6,000 | 334,697 | 5,722 | 11.7 K to 5.7 K (-51.19 %) |
Sep 21 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 27.34 | 6,000 | 164,063 | 11,722 | 5.7 K to 11.7 K (+104.86 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 367 | 4 | 5,722 | 5.4 K to 5.7 K (+6.85 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 354 | 4 | 5,083 | 4.7 K to 5.1 K (+7.49 %) |
Aug 03 2007 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 49.92 | 4,592 | 229,233 | 4,592 | |
Aug 03 2007 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 287 | 3 | 4,729 | 4.4 K to 4.7 K (+6.46 %) |
Aug 03 2006 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | P | 45.01 | 842 | 37,898 | 4,442 | 3.6 K to 4.4 K (+23.39 %) |
Aug 03 2006 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | P | 45.00 | 2,000 | 90,000 | 3,600 | 1.6 K to 3.6 K (+125.00 %) |
Aug 03 2006 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | P | 44.99 | 100 | 4,499 | 1,600 | 1.5 K to 1.6 K (+6.67 %) |
Aug 03 2006 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | P | 44.98 | 1,500 | 67,470 | 1,500 | 0 to 1.5 K |
May 09 2006 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 52.76 | 6,000 | 316,560 | 6,000 | |
Sep 06 2005 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 44.74 | 6,000 | 268,440 | 6,000 | |
May 07 2004 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 26.11 | 6,000 | 156,630 | 6,000 |
Page: 1